Acute Porphyria Drug Database

Monograph

J05AF06 - Abacavir
Propably not porphyrinogenic
PNP

Side effects
Common adverse reactions of abacavir that can be confused with an acute porphyric attack are nausea, vomiting and diarrhoea. These side effects may potentially be porphyrinogenic if leading to a decrease in carbohydrate intake.
Rationale
Abacavir is not a metabolized by CYP450 enzymes and is not an inducer or a mechanism-based inhibitor of CYP450 enzymes.
Chemical description
Nucleoside analogue
Therapeutic characteristics
Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI) indicated in the antiretroviral combination therapy for the treatment of HIV-1 infection in adults, adolescents and children. It is administered orally.
Metabolism and pharmacokinetics
Abacavir is mainly metabolized in the liver by alcohol dehydrogenase and by glucuronidation (SPC). Abacavir is not metabolized by CYP450 enzymes, and has been shown in vitro not to inhibit or induce CYP3A4, 2C9 and 2D6 (SPC). No drug-drug interactions with abacavir as perpetrator have been reported in the literature (interaktionsdatabasen.dk, Yuen 2008).
Similar drugs
Explore alternative drugs in similar therapeutic classes J05A / J05AF or go back.

References

# Citation details PMID
*Scientific articles
1. A review of the pharmacokinetics of abacavir.
Yuen GJ, Weller S, et al. Clin Pharmacokinet. 2008;47(6):351-71.
*Drug interaction databases
2. Interaktionsdatabasen. Abacavir.
*Summary of Product Characteristics
3. The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). (Ziagen).

Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Abacavir · Ziagen Ziagen Abacavir · Ziagen Abacavir · Ziagen Abacavir · Ziagen Ziagen Ziagen Abacavir · Ziagen Ziagen Ziagen Abacavir · Ziagen Ziagen
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙